Literature DB >> 19910688

Changes in human endothelial cell energy metabolic capacities during in vitro cultivation. The role of "aerobic glycolysis" and proliferation.

Kirsten Peters1, Gunter Kamp, Ansgar Berz, Ronald E Unger, Susanne Barth, Achim Salamon, Joachim Rychly, C James Kirkpatrick.   

Abstract

BACKGROUND: In this study the influence of cultivation and proliferation on energy metabolic characteristics of human umbilical vein endothelial cells (HUVEC) has been examined. The energy metabolic capacities of human endothelial cells freshly isolated from the umbilical vein were compared with those after cultivation for three passages and as subconfluent and confluent cultures.
METHODS: Expression of cell type-specific differentiation markers and proliferative activity were studied in dependency on cultivation characteristics. Furthermore, the energy metabolic characteristics of HUVEC were analyzed by measurement of the maximum catalytic activities of marker enzymes of various metabolic pathways.
RESULTS: Examination of a typical marker of proliferation, Ki67, confirmed that HUVEC changed in culture from a non-proliferative to a proliferative state. Compared to other cell types, the enzyme pattern of HUVEC showed a high glycolytic and a high NADPH regenerating capacity. These capacities increased by cultivation nearly to the same degree as marker enzymes of other metabolic pathways (e.g. citric acid cycle).
CONCLUSION: Our data support the theory that metabolism of EC is primarily by "aerobic glycolysis", i.e. the conversion of glucose to lactate in the presence of oxygen. These characteristics were independent of whether the cells are freshly isolated/non-proliferating or cell culture-adapted/proliferating. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19910688     DOI: 10.1159/000257490

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  21 in total

Review 1.  Metabolic Regulation of Angiogenesis in Diabetes and Aging.

Authors:  Naoki Sawada; Zolt Arany
Journal:  Physiology (Bethesda)       Date:  2017-07

Review 2.  Endothelial cell metabolism in health and disease: impact of hypoxia.

Authors:  Brian W Wong; Elke Marsch; Lucas Treps; Myriam Baes; Peter Carmeliet
Journal:  EMBO J       Date:  2017-06-21       Impact factor: 11.598

Review 3.  The Intratumoral Heterogeneity of Cancer Metabolism.

Authors:  Karim Nabi; Anne Le
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 4.  Endothelial Cell Metabolism.

Authors:  Guy Eelen; Pauline de Zeeuw; Lucas Treps; Ulrike Harjes; Brian W Wong; Peter Carmeliet
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 5.  MicroRNAs mediate metabolic stresses and angiogenesis.

Authors:  Francesca Patella; Giuseppe Rainaldi
Journal:  Cell Mol Life Sci       Date:  2011-08-14       Impact factor: 9.261

6.  The Intratumoral Heterogeneity of Cancer Metabolism.

Authors:  Karim Nabi; Anne Le
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors.

Authors:  Samuel K Houston; Yolanda Piña; Timothy G Murray; Hinda Boutrid; Colleen Cebulla; Amy C Schefler; Wei Shi; Magda Celdran; William Feuer; Jaime Merchan; Ted J Lampidis
Journal:  Clin Ophthalmol       Date:  2011-01-27

8.  Oncogene activation induces metabolic transformation resulting in insulin-independence in human breast cancer cells.

Authors:  Aliccia Bollig-Fischer; T Gregory Dewey; Stephen P Ethier
Journal:  PLoS One       Date:  2011-03-17       Impact factor: 3.240

Review 9.  Endothelial cell metabolism: parallels and divergences with cancer cell metabolism.

Authors:  Dries Verdegem; Stijn Moens; Peter Stapor; Peter Carmeliet
Journal:  Cancer Metab       Date:  2014-09-15

Review 10.  Endothelial cell metabolism and implications for cancer therapy.

Authors:  U Harjes; K Bensaad; A L Harris
Journal:  Br J Cancer       Date:  2012-10-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.